• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病患者急性呼吸衰竭行无创正压通气治疗后长期死亡的预测因素。

Predictors for long-term mortality in COPD patients requiring non-invasive positive pressure ventilation for the treatment of acute respiratory failure.

机构信息

Department of Respiratory Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.

NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.

出版信息

Clin Respir J. 2020 Dec;14(12):1144-1152. doi: 10.1111/crj.13251. Epub 2020 Sep 22.

DOI:10.1111/crj.13251
PMID:32780940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7756413/
Abstract

INTRODUCTION

The effectiveness of non-invasive mechanical ventilation (NIV) in the management of COPD patients suffering from acute respiratory failure (ARF) as a consequence of exacerbation of the disease, is well established. However, data on long-term outcomes and their predictors, including the individual response to NIV, are scarce.

OBJECTIVES

To investigate predictors for short- and long-term mortality in this study population.

METHODS

A retrospective cohort study was performed including all patients admitted to the Medium Respiratory Care Unit of Maastricht University Medical Center in Maastricht, the Netherlands, with hospitalized exacerbation of COPD (H-ECOPD) with ARF requiring NIV for the first time between January 2009 and December 2011. An extensive number of potential predictors of outcomes, including the response to NIV, were determined on admission and during hospitalization. Univariate and multivariate logistic regression was used for statistical analysis.

RESULTS

Seventy-eight consecutive patients with moderate to severe COPD (mean age 71.0 ± 10.7 years; 48.7% males) were included; In-hospital, 1-year and 2-year mortality rates were 14.1%, 43.6% and 56.4%, respectively. Independent risk factors for 2-year mortality were: advanced age (odds ratio(OR) 1.025; confidence interval (CI) 1.002-1.049; P = 0.037), prolonged NIV use more than 8 days (OR:1.054;CI:1.006-1.104; P = 0.027) and no successful response to NIV (OR:2.392;CI:1.297-4.413; P = 0.005).

CONCLUSION

Patients with an H-ECOPD requiring NIV for the first time, constitute a severely ill patient group with high in-hospital and 2-year mortality. This study identified advanced age, NIV use more than 8 days and unsuccessful response to NIV as clinical important independent predictors for long-term mortality.

摘要

引言

无创机械通气(NIV)在治疗因疾病加重而导致急性呼吸衰竭(ARF)的 COPD 患者方面的有效性已得到充分证实。然而,关于长期结果及其预测因素的数据,包括对 NIV 的个体反应,仍然很少。

目的

本研究旨在探讨该研究人群的短期和长期死亡率的预测因素。

方法

本研究采用回顾性队列研究设计,纳入了 2009 年 1 月至 2011 年 12 月期间在荷兰马斯特里赫特大学医学中心中呼吸重症监护病房(Medium Respiratory Care Unit)首次因 COPD 加重并发 ARF 而接受 NIV 治疗的住院患者。入院时和住院期间确定了大量潜在的预后预测因素,包括对 NIV 的反应。使用单变量和多变量逻辑回归进行统计分析。

结果

本研究纳入了 78 例中重度 COPD 患者(平均年龄 71.0 ± 10.7 岁,男性占 48.7%);住院期间、1 年和 2 年的死亡率分别为 14.1%、43.6%和 56.4%。2 年死亡率的独立危险因素包括:高龄(优势比(OR)为 1.025;95%置信区间(CI)为 1.002-1.049;P=0.037)、NIV 使用时间延长超过 8 天(OR:1.054;95%CI:1.006-1.104;P=0.027)和对 NIV 无反应(OR:2.392;95%CI:1.297-4.413;P=0.005)。

结论

首次因 COPD 加重并发 ARF 而需要接受 NIV 治疗的患者构成了一个病情严重的患者群体,其住院期间和 2 年死亡率均较高。本研究确定了高龄、NIV 使用时间超过 8 天和对 NIV 无反应是长期死亡率的重要独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/95c1fc4cb01e/CRJ-14-1144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/e215fa88c542/CRJ-14-1144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/944f06b011ce/CRJ-14-1144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/95c1fc4cb01e/CRJ-14-1144-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/e215fa88c542/CRJ-14-1144-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/944f06b011ce/CRJ-14-1144-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c85b/7756413/95c1fc4cb01e/CRJ-14-1144-g003.jpg

相似文献

1
Predictors for long-term mortality in COPD patients requiring non-invasive positive pressure ventilation for the treatment of acute respiratory failure.慢性阻塞性肺疾病患者急性呼吸衰竭行无创正压通气治疗后长期死亡的预测因素。
Clin Respir J. 2020 Dec;14(12):1144-1152. doi: 10.1111/crj.13251. Epub 2020 Sep 22.
2
Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.无创通气用于治疗慢性阻塞性肺疾病急性加重所致的急性高碳酸血症性呼吸衰竭。
Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD004104. doi: 10.1002/14651858.CD004104.pub4.
3
Long-term outcomes in patients with COPD treated with non-invasive ventilation for acute hypercapnic respiratory failure.慢性阻塞性肺疾病患者急性高碳酸血症呼吸衰竭接受无创通气治疗的长期结局。
Ir J Med Sci. 2024 Oct;193(5):2413-2418. doi: 10.1007/s11845-024-03690-w. Epub 2024 May 15.
4
Hospital Noninvasive Ventilation Case Volume and Outcomes of Acute Exacerbations of Chronic Obstructive Pulmonary Disease.医院无创通气病例量与慢性阻塞性肺疾病急性加重的结局。
Ann Am Thorac Soc. 2016 Oct;13(10):1752-1759. doi: 10.1513/AnnalsATS.201603-209OC.
5
Performance of noninvasive ventilation in acute respiratory failure in critically ill patients: a prospective, observational, cohort study.无创通气在危重症患者急性呼吸衰竭中的应用:一项前瞻性观察性队列研究。
BMC Pulm Med. 2015 Nov 11;15:144. doi: 10.1186/s12890-015-0139-3.
6
Impact of anemia on short-term survival in severe COPD exacerbations: a cohort study.贫血对重度慢性阻塞性肺疾病急性加重期短期生存的影响:一项队列研究
Int J Chron Obstruct Pulmon Dis. 2016 Aug 1;11:1775-83. doi: 10.2147/COPD.S111758. eCollection 2016.
7
Predictors of outcome of noninvasive ventilation in severe COPD exacerbation.无创通气治疗重度 COPD 加重的结局预测因素。
BMC Pulm Med. 2019 Jul 18;19(1):131. doi: 10.1186/s12890-019-0892-9.
8
Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重住院患者的有创和无创通气相关结局。
JAMA Intern Med. 2014 Dec;174(12):1982-93. doi: 10.1001/jamainternmed.2014.5430.
9
Early failure of noninvasive ventilation in chronic obstructive pulmonary disease with acute hypercapnic respiratory failure.慢性阻塞性肺疾病合并急性高碳酸血症呼吸衰竭患者无创通气的早期失败
Intern Emerg Med. 2015 Oct;10(7):855-60. doi: 10.1007/s11739-015-1293-6. Epub 2015 Sep 4.
10
Use of noninvasive ventilation in patients with acute respiratory failure, 2000-2009: a population-based study.2000-2009 年急性呼吸衰竭患者使用无创通气:一项基于人群的研究。
Ann Am Thorac Soc. 2013 Feb;10(1):10-7. doi: 10.1513/AnnalsATS.201206-034OC.

引用本文的文献

1
Factors Influencing Mechanical Ventilation and Inpatient Palliative Care Utilization in Patients With Chronic Obstructive Pulmonary Disease.影响慢性阻塞性肺疾病患者机械通气和住院姑息治疗使用的因素
J Multidiscip Healthc. 2025 Mar 20;18:1695-1709. doi: 10.2147/JMDH.S509022. eCollection 2025.
2
What Is the Potential Value of a Randomized Trial of Different Thresholds to Initiate Invasive Ventilation? A Health Economic Analysis.不同有创机械通气起始阈值随机试验的潜在价值是什么?一项卫生经济学分析。
Crit Care Explor. 2024 Jun 4;6(6):e1098. doi: 10.1097/CCE.0000000000001098. eCollection 2024 Jun 1.
3
Long-term outcomes in patients with COPD treated with non-invasive ventilation for acute hypercapnic respiratory failure.

本文引用的文献

1
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges.《慢性阻塞性肺疾病诊断、管理和预防全球策略2019报告:未来挑战》
Arch Bronconeumol (Engl Ed). 2020 Feb;56(2):65-67. doi: 10.1016/j.arbres.2019.06.001. Epub 2019 Jul 15.
2
Predictors of outcome of noninvasive ventilation in severe COPD exacerbation.无创通气治疗重度 COPD 加重的结局预测因素。
BMC Pulm Med. 2019 Jul 18;19(1):131. doi: 10.1186/s12890-019-0892-9.
3
Risk stratification for short-term mortality at hospital admission for acute exacerbations of COPD.
慢性阻塞性肺疾病患者急性高碳酸血症呼吸衰竭接受无创通气治疗的长期结局。
Ir J Med Sci. 2024 Oct;193(5):2413-2418. doi: 10.1007/s11845-024-03690-w. Epub 2024 May 15.
4
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients.慢性阻塞性肺疾病加重相关住院后的全球死亡率和再入院率:对65945例个体患者的荟萃分析
ERJ Open Res. 2024 Feb 26;10(1). doi: 10.1183/23120541.00838-2023. eCollection 2024 Jan.
5
Clinical practice of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期无创通气的临床实践。
Respir Res. 2023 Aug 23;24(1):208. doi: 10.1186/s12931-023-02507-1.
6
Acute COPD exacerbation treatment with noninvasive ventilation.无创通气治疗急性 COPD 加重。
Sci Rep. 2023 Apr 21;13(1):6586. doi: 10.1038/s41598-023-33871-z.
7
Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal.急性加重期慢性阻塞性肺疾病患者的高碳酸血症性呼吸衰竭:严重气流受限作为早期预警信号
J Clin Med. 2022 Dec 29;12(1):258. doi: 10.3390/jcm12010258.
8
High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study.高压力无创通气治疗 COPD 急性高碳酸血症性呼吸衰竭:一项回顾性队列研究的生存率改善。
BMJ Open Respir Res. 2022 Jun;9(1). doi: 10.1136/bmjresp-2022-001260.
慢性阻塞性肺疾病急性加重住院患者短期死亡率的风险分层。
Respirology. 2019 Aug;24(8):765-776. doi: 10.1111/resp.13538. Epub 2019 Mar 21.
4
Management of severe acute exacerbations of COPD: an updated narrative review.慢性阻塞性肺疾病严重急性加重的管理:一项更新的叙述性综述
Multidiscip Respir Med. 2018 Oct 2;13:36. doi: 10.1186/s40248-018-0149-0. eCollection 2018.
5
Dyspnoea in patients receiving noninvasive ventilation for acute respiratory failure: prevalence, risk factors and prognostic impact: A prospective observational study.急性呼吸衰竭患者接受无创通气时的呼吸困难:患病率、危险因素和预后影响:一项前瞻性观察研究。
Eur Respir J. 2018 Aug 9;52(2). doi: 10.1183/13993003.02637-2017. Print 2018 Aug.
6
Acute respiratory failure requiring mechanical ventilation in severe chronic obstructive pulmonary disease (COPD).重度慢性阻塞性肺疾病(COPD)中需要机械通气的急性呼吸衰竭
Medicine (Baltimore). 2018 Apr;97(17):e0487. doi: 10.1097/MD.0000000000010487.
7
Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者住院后第一年再入院和死亡的风险轨迹。
Am J Respir Crit Care Med. 2018 Apr 15;197(8):1009-1017. doi: 10.1164/rccm.201709-1852OC.
8
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.COPD 加重的管理:欧洲呼吸学会/美国胸科学会指南。
Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.00791-2016. Print 2017 Mar.
9
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。
Eur Respir J. 2017 Mar 6;49(3). doi: 10.1183/13993003.00214-2017. Print 2017 Mar.
10
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.